paroxetine has been researched along with Chronic Insomnia in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, M; Freeman, J; Marek, GJ; Walzer, M; Wu, R; Zammit, G | 1 |
| Baldwin, DS; Everitt, H; Lipinska, G; Malizia, AL; Manson, CC; Mayers, A; Stuart, B; Wilson, S | 1 |
| Ball, W; Cai, B; DeMuro, C; Morrison, MF; Snyder, E | 1 |
| Liu, Y; Mao, HJ; Song, MF; Tang, GZ; Wang, SD; Xu, XH; Yin, Y; Yu, ZH | 1 |
| Dotan, Y; Pillar, G; Suraiya, S | 1 |
| Borgeat, F; Hättenschwiler, J; Khazaal, Y; Mattia, M; Stankovic, M; Zullino, DF | 1 |
| Heinz, A; Ströhle, A; Trendelenburg, G | 1 |
| Demitrack, MA; Detke, MJ; Goldstein, DJ; Lu, Y; Mallinckrodt, C; Wiltse, C | 1 |
| Berard, R; Carpenter, DJ; Davy, K; Gee, M; Machin, A; Perera, P; Stein, MB; Wagner, KD; Wetherhold, E | 1 |
| Gelenberg, AJ; Liebowitz, MR; Munjack, D | 1 |
| Benedetti, F; Colombo, C; Cusin, C; Mandelli, L; Pirovano, A; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
| Christi, JA; Perera, P; Pitts, CD; Roy-Byrne, PP | 1 |
| Bhanji, NH; Chouinard, G; Kolivakis, T; Margolese, HC | 1 |
| Buysse, DJ; Hall, M; Mazumdar, S; Miller, MD; Pollock, BG; Reynolds, CF | 1 |
| Akiyama, K; Hirokane, G; Morita, S; Okawa, M; Saeki, Y; Shimoda, K; Ueda, M; Watanabe, T | 1 |
| Chen, ZQ; Ji, JL; Liu, WJ; Mei, QY; Pan, JY; Tao, M; Wang, YP; Wei, J; Zhang, N; Zhao, ZX; Zheng, AL | 1 |
| Danhof, M; Della Pasqua, O; Gomeni, R; Santen, G | 1 |
| Meyer, C | 1 |
| Hawley, CJ; McPhee, S; Pattinson, HA; Quick, SJ; Ratnam, S | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Buysse, DJ; Dew, MA; Kupfer, DJ; Nowell, PD; Reynolds, CF | 1 |
| Carrier, L | 1 |
| Musa, MN | 1 |
| Fava, M; Gonzales, JS; Hoog, SL; Judge, RA; Kopp, JB; Nilsson, ME | 1 |
| Culpepper, L | 1 |
6 review(s) available for paroxetine and Chronic Insomnia
| Article | Year |
|---|---|
Antidepressants for insomnia in adults.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Fluoxetine; Humans; Mianserin; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Trazodone | 2018 |
[Pharmacotherapy of generalized anxiety disorder: state of the art].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Benzodiazepines; Child; Child, Preschool; Cyclohexanols; Double-Blind Method; Humans; Meta-Analysis as Topic; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Time Factors; Venlafaxine Hydrochloride | 2003 |
Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Cohort Studies; Depressive Disorder; Ethnicity; Female; Humans; Male; Middle Aged; Minority Groups; Nausea; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Survival Analysis; Treatment Outcome | 2005 |
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
Topics: Aged; Akathisia, Drug-Induced; Anxiety; Female; Humans; Panic Disorder; Paroxetine; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 2006 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Generalized anxiety disorder in primary care: emerging issues in management and treatment.
Topics: Adaptation, Psychological; Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Physicians, Family; Prevalence; Primary Health Care; Recurrence; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; United States; Venlafaxine Hydrochloride | 2002 |
13 trial(s) available for paroxetine and Chronic Insomnia
| Article | Year |
|---|---|
A randomized phase 1 single-dose polysomnography study of ASP8062, a GABA
Topics: Adult; Electroencephalography; Female; GABA Modulators; Humans; Male; Middle Aged; Morpholines; Paroxetine; Polysomnography; Pyrimidines; Receptors, GABA-B; Sleep Initiation and Maintenance Disorders; Sleep, REM; Sleep, Slow-Wave | 2021 |
A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression.
Topics: Adult; Aged; Aprepitant; Comorbidity; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine; Psychometrics; Reproducibility of Results; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires | 2018 |
Effect and safety of paroxetine combined with zolpidem in treatment of primary insomnia.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Pyridines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Wakefulness; Zolpidem | 2017 |
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
Topics: Adult; Analysis of Variance; Confidence Intervals; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Sleep Initiation and Maintenance Disorders; Thiophenes | 2004 |
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
Topics: Adolescent; Age Factors; Ambulatory Care; Child; Double-Blind Method; Drug Administration Schedule; Feeding and Eating Disorders; Female; Humans; Male; Paroxetine; Personality Inventory; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting | 2004 |
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.
Topics: Adult; Aged; Antidepressive Agents; CLOCK Proteins; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Mood Disorders; Multivariate Analysis; Paroxetine; Pindolol; Polymorphism, Genetic; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Time Factors; Trans-Activators; Treatment Outcome | 2005 |
Paroxetine treatment of primary insomnia in older adults.
Topics: Aged; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Failure | 2006 |
High plasma concentrations of paroxetine impede clinical response in patients with panic disorder.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Asian People; Azepines; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Sleep Initiation and Maintenance Disorders; Time Factors | 2007 |
[Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study].
Topics: Antidepressive Agents, Second-Generation; Depression; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Outcome Assessment, Health Care; Paroxetine; Pyridines; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Zolpidem | 2007 |
Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients.
Topics: Adult; Benzamides; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Nausea; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 1996 |
Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; Electroencephalography; Female; Humans; Male; Middle Aged; Multivariate Analysis; Paroxetine; Personality Inventory; Pilot Projects; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome | 1999 |
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality Inventory; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2002 |
7 other study(ies) available for paroxetine and Chronic Insomnia
| Article | Year |
|---|---|
[Sleep spindles in post traumatic stress disorder: significant importance of selective serotonin reuptake inhibitors].
Topics: Citalopram; Electromyography; Electrooculography; Humans; Paroxetine; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep, REM; Stress Disorders, Post-Traumatic; Wakefulness | 2008 |
Are SSRIs safe for children?
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Depression; Fatigue; Humans; Nausea; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 2003 |
Gamma-hydroxybutyrate dependence with social phobia.
Topics: Adjuvants, Anesthesia; Adult; Cognitive Behavioral Therapy; Humans; Male; Paroxetine; Phobic Disorders; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Sodium Oxybate | 2004 |
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.
Topics: Depressive Disorder, Major; Double-Blind Method; Endpoint Determination; False Negative Reactions; Humans; Linear Models; Longitudinal Studies; Paroxetine; Placebos; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Initiation and Maintenance Disorders; Suicide; Time Factors; Treatment Outcome | 2008 |
New drugs. In the realm of the brain.
Topics: Central Nervous System Agents; Depression; Humans; Hypnotics and Sedatives; Migraine Disorders; Paroxetine; Pyridines; Sleep Initiation and Maintenance Disorders; Sumatriptan; Zolpidem | 1993 |
Donepezil and paroxetine: possible drug interaction.
Topics: Aged; Aggression; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Confusion; Diarrhea; Donepezil; Drug Interactions; Female; Flatulence; Humans; Indans; Male; Nootropic Agents; Paroxetine; Piperidines; Sleep Initiation and Maintenance Disorders | 1999 |
Paroxetine for primary insomnia: possible placebo effect?
Topics: Clinical Trials as Topic; Humans; Paroxetine; Placebo Effect; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 1999 |